Integrin-linked kinase functions as a downstream mediator of endothelin-1 to promote invasive behavior in ovarian carcinoma.
about
Endothelin-1 inhibits prolyl hydroxylase domain 2 to activate hypoxia-inducible factor-1alpha in melanoma cells.Modulation of microvascular smooth muscle adhesion and mechanotransduction by integrin-linked kinase.The function of integrin-linked kinase in normal and activated stellate cells: implications for fibrogenesis in wound healingAdenovirus-mediated overexpression of cardiac troponin I-interacting kinase promotes cardiomyocyte hypertrophy.Expression of parvin-beta is a prognostic factor for patients with urothelial cell carcinoma of the upper urinary tract.Macitentan (ACT-064992), a tissue-targeting endothelin receptor antagonist, enhances therapeutic efficacy of paclitaxel by modulating survival pathways in orthotopic models of metastatic human ovarian cancer.Maslinic acid-enriched diet decreases intestinal tumorigenesis in Apc(Min/+) mice through transcriptomic and metabolomic reprogrammingBruton's tyrosine kinase (Btk) inhibitor ibrutinib suppresses stem-like traits in ovarian cancer.Loss expression of micro ribonucleic acid (miRNA)-200c induces adverse post-surgical prognosis of advanced stage non-small cell lung carcinoma and its potential relationship with ETAR messenger RNAMigfilin, α-parvin and β-parvin are differentially expressed in ovarian serous carcinoma effusions, primary tumors and solid metastases.Using Pharmacokinetic Profiles and Digital Quantification of Stained Tissue Microarrays as a Medium-Throughput, Quantitative Method for Measuring the Kinetics of Early Signaling Changes Following Integrin-Linked Kinase Inhibition in an In Vivo ModelmiR-30a inhibits endothelin A receptor and chemoresistance in ovarian carcinoma.Epithelial-mesenchymal transition in ovarian cancer progression: a crucial role for the endothelin axis.Alpha-v integrins as therapeutic targets in oncology.Beta-arrestin links endothelin A receptor to beta-catenin signaling to induce ovarian cancer cell invasion and metastasis.Contributions of integrin-linked kinase to breast cancer metastasis and tumourigenesis.Integrin-linked kinase activity modulates the pro-metastatic behavior of ovarian cancer cells.Stromal endothelin B receptor-deficiency inhibits breast cancer growth and metastasis.Cardioprotective signaling by endothelinβ-arrestin-1 drives endothelin-1-mediated podocyte activation and sustains renal injury.Cross-talk between the insulin-like growth factor (IGF) axis and membrane integrins to regulate cell physiology.The Role of Endocrine G Protein-Coupled Receptors in Ovarian Cancer Progression.The importance of endothelin axis in initiation, progression, and therapy of ovarian cancer.Integrin-linked kinase 1: role in hormonal cancer progression.Link between cancer and Alzheimer disease via oxidative stress induced by nitric oxide-dependent mitochondrial DNA overproliferation and deletionA pharmacogenetic study of docetaxel and thalidomide in patients with castration-resistant prostate cancer using the DMET genotyping platform.Loss of SLCO1B3 drives taxane resistance in prostate cancerAcetyl-L-Carnitine Prevents Methamphetamine-Induced Structural Damage on Endothelial Cells via ILK-Related MMP-9 Activity.Endothelin-1 promotes vascular endothelial growth factor-dependent angiogenesis in human chondrosarcoma cells.c-Jun N-terminal kinase is involved in the regulation of proliferation and apoptosis by integrin-linked kinase in human retinoblastoma cells.Beta-arrestin-1 mediates the endothelin-1-induced activation of Akt and integrin-linked kinase.DNAzymes to mouse beta1 integrin mRNA in vivo: targeting the tumor vasculature and retarding cancer growth.β-arrestin-1 is a nuclear transcriptional regulator of endothelin-1-induced β-catenin signaling.Targeting endothelin-1 receptor/β-arrestin1 network for the treatment of ovarian cancer.
P2860
Q33614677-6E95EFF6-CC1A-44D6-A36D-4668C370A029Q34073868-9C9B7ACD-D9EB-4394-85AA-28235AE1358BQ34118683-D603CFD5-61CB-4112-BF1C-9D90D16B92EBQ34164033-DB31E18B-3DD1-494E-BF83-5C2418D12E53Q34253712-C2965383-92FC-4F7D-94D1-6FC1B79FD416Q34551567-70A4FDEA-CBC1-4D5E-9059-915D22EE01DCQ34635123-CA8A77B4-C030-411E-B8C2-E9D0562E6141Q35650181-D71E8356-30CA-45BC-B62B-F37D36E41F70Q35879380-670EBFB8-AB9C-4881-BA31-6166708ACAA2Q36553567-0D39656C-71FE-4024-AE54-D1A83D8D6411Q36720975-39A7CD61-060E-49A7-BFEB-E10DE5E3D2EFQ36782334-01778BA0-3BB7-4B63-B90E-7EA2EB91B8A8Q36857782-BEC46DDD-F92A-49A9-9028-7355F301FB6FQ37008623-FA1D7671-002A-4765-B024-D5888C290487Q37115261-F0C196AE-1CA0-48B3-AB5C-6CDA5B466342Q37118092-7C315788-1E00-49F4-9901-5CF036BD940BQ37225450-BB9D71FF-9B75-4FEC-88EA-2DFC78318978Q37310022-2788E510-C2E2-4507-BD74-0E9858F616E8Q37397982-2EE24AC2-8214-4D4A-A628-DAA417485A6FQ37604733-98D886FA-7C8C-49B2-8F63-47321AD2AB05Q37740002-68501672-0BDB-4777-B2A8-11D2D837EFBDQ37740526-7B41A22D-0EBE-4D68-BC0F-21B1302474E7Q37764250-B0BDE80F-21EC-4E23-98B1-1808220FE9F7Q37825335-99F98D6E-50A5-4CDA-9320-347A0214674AQ38108308-428D9CBD-2294-4DDA-A982-340F5810EBA0Q38347610-51386CFF-D9A7-4228-AEC6-A8EA2D771242Q38751260-46410506-D2E3-4DA8-8DDF-F20E5E2DC0B7Q38933060-7EE714E3-0D0B-467A-87BA-306A124BC693Q39166807-19044316-75BA-49D0-9544-207052CC0225Q39608009-95D8B176-EC7D-40E0-841B-29BBB0B78C5FQ39665356-8F85883D-F236-4D4F-A240-35D7DD9EC014Q39879193-E84D456F-7C91-4005-B9BE-AFB69AE35CACQ44686499-A7AD9B56-D302-4677-ADC4-857D163EE4B7Q48010163-67287E04-8C7C-4779-9E1A-8127317D7A65
P2860
Integrin-linked kinase functions as a downstream mediator of endothelin-1 to promote invasive behavior in ovarian carcinoma.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Integrin-linked kinase functio ...... behavior in ovarian carcinoma.
@en
type
label
Integrin-linked kinase functio ...... behavior in ovarian carcinoma.
@en
prefLabel
Integrin-linked kinase functio ...... behavior in ovarian carcinoma.
@en
P2093
P50
P1476
Integrin-linked kinase functio ...... behavior in ovarian carcinoma
@en
P2093
Francesca Spinella
Maria Rita Nicotra
Pier Giorgio Natali
P304
P356
10.1158/1535-7163.MCT-05-0523
P577
2006-04-01T00:00:00Z